4//SEC Filing
MACFARLANE M DAVID 4
Accession 0001104659-21-020188
CIK 0000910267other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:31 AM ET
Size
5.2 KB
Accession
0001104659-21-020188
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
MACFARLANE M DAVID
Director
Transactions
- Award
Option to Purchase Common Stock
2021-02-10+25,000→ 25,000 totalExercise: $4.02From: 2021-08-10Exp: 2031-02-10→ Common Stock (25,000 underlying)
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001182314
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:31 AM ET
- Size
- 5.2 KB